Wei-Teng Yang, MD MPH AAHIVS FASAM FACP
Assistant Professor of Clinical Medicine (Infectious Diseases)
Director of Infectious Diseases Addiction Medicine Integration, Division of Infectious Diseases, Department of Medicine
Physician Member, Multidisciplinary substance use associated infective endocarditis team at the Hospital of the University of Pennsylvania
Physician Member, Penn Center for Addiction Medicine and Policy
Per diem Infectious Diseases physician, Chester County Hospital
Department: Medicine
Contact information
3400 Spruce Street, Silverstein 3F, Suite E
Philadelphia, PA 19104
Philadelphia, PA 19104
Education:
MD
National Cheng Kung University College of Medicine, Taiwan, 2007.
MPH
Johns Hopkins University, 2010.
Permanent linkMD
National Cheng Kung University College of Medicine, Taiwan, 2007.
MPH
Johns Hopkins University, 2010.
Description of Clinical Expertise
Dr. Yang practices in infectious diseases and addiction medicine in the Hospital of the University of Pennsylvania and the Presbyterian Hospital. His clinical and academic interests are in the integration of infectious diseases and addiction care, and implementation of care models. He has extensive experiences working with marginalized populations and views addiction as the root cause of many infectious diseases. In his role of the Director of Infectious Diseases – Addiction Medicine Integration in the Division of Infectious Diseases, Dr. Yang sees inpatient consultations with the infectious diseases and addiction medicine teams and maintains an outpatient practice where he sees patients with concurrent infections and addiction. He is also involved in multidisciplinary work in infective endocarditis and xylazine associated wounds within the Penn health system.Selected Publications
Yang, WT, Meisner, JA, Maguire, C, Dyer, KE, McFadden, R, Thakrar , AP, Dickinson, DT, Berg, D, Preston, A, David, MZ, Perrone, J, Talati, N, Degnan, KO.: Multidisciplinary Guidance to Care for Persons With Xylazine-Associated Wounds. Open Forum Infect Dis 12(6), Jun 2025.Ladines-Lim, JB,, Yang, WT, Tebas, P, O'Donnell, J, Koenig, H, Kreider, E, Dyer, K, Anwar, M, Rodriguez, E, Patel, S, Rodino, K, Glaser, L, Richterman, A.: Delayed diagnosis of disseminated Mycobacterium intracellulare subsp. chimaera infective endocarditis via cell-free metagenomic next-generation sequencing: a case report. ASM Case Reports ahead of print, May 2025.
Stopka, TJ, Nance, RM, Mixson, LS, Spencer, H, Tsui, JI, Leahy,JM, Pho, MT, DeJace, J, Feinberg, J, Young, AM, Yang, WT, Baltes, A, Romo, E, Brown, RT, Nolte, K, Miller, WC, Zule, WA, Jenkins, WD, Delaney, JA, Friedmann, PD.: Serious Bacterial Infections and Hepatitis C Virus Among People Who Inject Drugs: A Syndemic or Intertwined Epidemics? Trop Med Infect Dis 10(1): 17, Jan 2025.
Liu, AW, Yang, WT, Glick, SN, Kim, HN, Beieler, AM, Lan, KF, Dhanireddy, S, Tsui, JI.: Stimulant Co-use Is Associated With Patient-directed Discharges in Hospitalized Patients with Opioid Use and Injection Drug Use Related Infections. J Addict Med 17(6): 646-647, Sep 2023.
Yang WT, Dombrowski JC, Glick SN, Kim HN, Beieler AM, Lan KF, Dhanireddy S.: Partial-Oral Antibiotic Therapy for Bone and Joint Infections in People With Recent Injection Drug Use. Open Forum Infect Dis 10(1): 5, Jan 2023.
Shivakoti R, Ewald ER, Gupte N, Yang WT, Kanyama C, Cardoso SW, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo U, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Pollard R, Detrick B, Balagopal A, Asmuth DM, Semba RD, Campbell TB, Golub J, Gupta A; NWCS 319 and ACTG PEARLS Study Team.: Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial. Clin Nutr 38(3): 1303-1309, Jun 2019.
Yang WT, Grant M.: Actinomyces neuii: a case report of a rare cause of acute infective endocarditis and literature review. BMC Infect Dis 19(1): 511, Jun 2019.
Tenforde MW, Yadav A, Dowdy DW, Gupte N, Shivakoti R, Yang WT, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Berendes S, Lama JR, Cardoso SW, Sugandhavesa P, Christian P, Semba RD, Campbell TB, Gupta A; NWCS319 and ACTG 5175 study team.: Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study. J Acquir Immune Defic Syndr 75(3): e71-e79, Jul 2017.
Balagopal A, Gupte N, Shivakoti R, Cox AL, Yang WT, Berendes S, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Lama JR, Cardoso SW, Sugandhavesa P, Semba RD, Hakim J, Hosseinipour MC, Kumarasamy N, Sanne I, Asmuth D, Campbell T, Bollinger RC, Gupta A.: Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort. Open Forum Infect Dis 3(3): ofw118, Jul 2016.
Shivakoti R, Yang WT, Berendes S, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Lama JR, Cardoso SW, Sugandhavesa P, Balagopal A, Gupte N, Semba RD, Campbell TB, Bollinger RC, Gupta A; NWCS 319 and PEARLS Study Team.: Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings. J Infect Dis 213(7): 1074-8, Apr 2016.